| Literature DB >> 34131878 |
Benjamin E Ueberroth1, Helene R Labonte2, Mark R Wallace2.
Abstract
BACKGROUND: Patient portal messages have been used in a variety of ways to facilitate improved communication between provider and patient. These platforms have shown promise in many ways for improving various health outcomes and overall communication between patient and provider.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34131878 PMCID: PMC8205315 DOI: 10.1007/s11606-021-06941-z
Source DB: PubMed Journal: J Gen Intern Med ISSN: 0884-8734 Impact factor: 6.473
Figure 1Inclusion criteria and randomization diagram.
Characteristics and Prevalence of Comorbidities in Study Groupsa
| Control | Intervention | ||||
|---|---|---|---|---|---|
| All patients ( | No message ( | Message alone ( | Message + scheduling ( | ||
| Age-median (years) | 62.3 | 62.4 | 62.5 | 62.0 | 0.506 |
| Female (%) | 52.4 | 51.9 | 52.3 | 53.0 | 0.544 |
| BMI-median (kg/m2) | 26.9 | 26.9 | 26.9 | 26.9 | 0.628 |
| Smoking status (%) | 0.700 | ||||
| Never smoker | 60.0 | 60.0 | 59.8 | 60.1 | |
| Former smoker | 30.6 | 30.7 | 31.1 | 30.1 | |
| Current smoker | 4.0 | 4.0 | 3.7 | 4.1 | |
| Not on file | 5.4 | 5.3 | 5.4 | 5.5 | |
| COPD (%) | 1.7 | 1.5 | 1.7 | 1.9 | 0.429 |
| Hypertension (%) | 33.9 | 34.2 | 33.5 | 33.9 | 0.675 |
| CHF (%) | 1.8 | 1.8 | 1.7 | 1.9 | 0.716 |
| CAD (%) | 11.2 | 11.1 | 11.8 | 10.7 | 0.222 |
| CKD (%) | 4.6 | 4.9 | 4.5 | 4.3 | 0.327 |
| Liver disease (%) | 4.8 | 4.5 | 4.8 | 5.0 | 0.453 |
aCOPD, chronic obstructive pulmonary disease; CHF, congestive heart failure; CAD, coronary artery disease; CKD, chronic kidney disease
Vaccination Rates of Control and Intervention Groups in Study Period